Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
Enrico Fabris1, Abi Selvarajah2, Annerieke Tavenier2
1Cardiovascular Department, University of Trieste, Trieste, Italy.
Summary
This review examines complementary therapies for ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). It questions the safety and efficacy of common treatments like morphine, beta-blockers, and oxygen, suggesting selective use of others.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Antithrombotic therapy is crucial for primary percutaneous coronary intervention (PCI).
- Acute management of ST-elevation myocardial infarction (STEMI) involves pain relief and cardioprotective strategies.
- Recent evidence questions the safety and efficacy of some standard treatments.
Purpose of the Study:
- To critically review complementary pharmacotherapy for STEMI patients undergoing primary PCI.
- To provide an updated perspective on modern treatment approaches.
- To evaluate the role of adjunctive therapies beyond standard antithrombotic treatment.
Main Methods:
- Literature review of recent evidence.
- Critical analysis of safety and efficacy data.
- Focus on pharmacotherapy in STEMI patients undergoing primary PCI.
Main Results:
- Morphine use raises concerns regarding interactions with P2Y12 inhibitors.
- Early beta-blocker treatment shows conflicting results on clinical outcomes.
- Supplemental oxygen lacks proven benefit in non-hypoxic patients and may cause harm.
Conclusions:
- Some commonly used adjunctive therapies in STEMI management require cautious application.
- Selective use of certain complementary treatments may be beneficial.
- An updated, critical approach to pharmacotherapy is essential for STEMI patients undergoing primary PCI.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.4K
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
11.8K
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
42
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
42
01:27Coronary Artery Disease V: Interprofessional Care
49
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
49
01:30Acute Coronary Syndrome I: Introduction
98
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
98
01:26Angina IV: Management
39
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
39
01:27Peripheral Artery Disease III: Interprofessional Care
43
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
43
01:26Atherosclerosis III: Management
54
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
54